Pyruvate Dehydrogenase Deficiency Presenting as Intermittent Isolated Acute Ataxia

Abstract

Objective: The aim of this study is to report and emphasize unusual presentations of pyruvate dehydrogenase (PDH) deficiency (OMIM 312170).

Methods: PDH activity and PDHA1 gene were studied in two siblings presenting with intermittent ataxia in childhood. Similar presentations in reported PDH-deficient patients were searched for using the Medline database.

Results: Both patients had PDH deficiency caused by a new mutation (G585C) in the PDHA1 gene, which is predicted to replace a highly conserved glycine at codon 195 by alanine. Although this mutation lies within the thiamine pyrophosphate binding domain, there was no thiamine responsiveness in vivo. The patients presented recurrent episodes of acute isolated ataxia in infancy. Both had normal blood and CSF lactate levels. Although symptoms initially resolved between episodes during the first decade, both patients subsequently worsened and developed progressive and severe encephalopathy, leading to death in their twenties. The spectrum of intermittent presentations in PDH deficiency includes episodic ataxia, intermittent peripheral weakness, recurrent dystonia and extrapyramidal movement disorders.

Conclusions: PDH deficiency should be considered in patients with unexplained intermittent and recurrent acute neurological symptoms. Long-term prognosis and outcome remain uncertain. PDH deficiency can occur even with normal CSF lactate concentration.

Key words

episodic ataxia - intermittent symptoms - pyruvate dehydrogenase deficiency

References

• 1 Bindoff LA, Birch-Machin MA, Farnsworth L, Gardner-Medwin D, Lindsay JG, Turnbull DM. Familial intermittent ataxia due to a defect of the E1 component of pyruvate dehydrogenase complex.  J Neurol Sc. 1989;  93 311-318
• 2 Blass JP, Avigan J, Uhlendorf BW. A defect in pyruvate decarboxylase in a child with an intermittent movement disorder.  J Clin Invest. 1970;  49 423-432
• 3 Brown GK, Haan EA, Kirby DM, Scholem RD, Wraith JE, Rogers JG. et al . Cerebral lactic acidosis: defects in pyruvate metabolism with profound brain damage and minimal systemic acidosis.  Eur J Pediatr. 1988;  147 10-14
• 4 Cameron JM, Levandovskiy V, Mackay N, Tein I, Robinson BH. Deficiency of pyruvate dehydrogenase caused by novel and known mutations in the E1 alpha gene.  Am J Med Genet A. 2004;  131 59-66
• 5 Debray FG, Lambert M, Vanasse M, Decarie JC, Cameron J, Levandovskiy V. et al . Intermittent peripheral weakness as the presenting feature of pyruvate dehydrogenase deficiency.  Eur J Pediatr. 2006;  165 462-466
• 6 Debray FG, Mitchell GA, Allard P, Robinson BH, Hanley JA, Lambert M. Diagnostic accuracy of blood lactate-to-pyruvate molar ratio in the differential diagnosis of congenital lactic acidosis.  Clin Chem. 2007;  53 916-921
• 7 Head RA, Goede CG de, Newton RW, Walter JH, MacShane M, Brown RM. et al . Pyruvate dehydrogenase deficiency presenting as dystonia in childhood.  Dev Med Child Neurol. 2004;  46 710-712
• 8 Lissens W, DeMeirleir L, Seneca S, Liebars I, Brown GK, Brown RM. et al . Mutation in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency.  Hum Mutat. 2000;  15 209-219
• 9 Livingstone IR, Gardner-Medwin D, Pennington RJ. Familial intermittent ataxia with possible X-linked recessive inheritance. Two patient with abnormal abnormal pyruvate metabolism and a response to acetazolamide.  J Neurol Sci. 1984;  64 89-97
• 10 Marsac C, Beneli C, Desguerre I, Diry M, Fouque F, Meirleir L De. et al . Biochemical and genetic studies of four patients with pyruvate dehydrogenase E1 alpha deficiency.  Hum Genet. 1997;  99 785-792
• 11 Mellick G, Price L, Boyle R. Late-onset presentation of pyruvate dehydrogenase deficiency.  Mov Disord. 2004;  19 727-729
• 12 Naito E, Ito M, Yokota I, Saijo T, Ogawa Y, Kuroda Y. Diagnosis and molecular analysis of three male patients with thiamine-responsive pyruvate dehydrogenase complex deficiency.  J Neurol Sci. 2002;  201 33-37
• 13 Naito E, Ito M, Yokota I, Saijo T, Matsuda J, Ogawa Y. et al . Thiamine-responsive pyruvate dehydrogenase deficiency in two patients caused by a point mutation (F205L and L216F) within the thiamine pyrophosphate binding region.  Biochem Biophys Acta. 2002;  1588 79-84
• 14 Old SE, DeVivo DC. Pyruvate dehydrogenase complex deficiency: biochemical and immunoblot analysis of cultured skin fibroblasts.  Ann Neurol. 1989;  26 746-751
• 15 Robinson BH, MacMillan H, Petrova-Benedict R, Sherwood WG. Variable clinical presentation with defective E1 component of the pyruvate dehydrogenase complex.  J Pediatr. 1987;  111 525-533
• 16 Robinson BH. Lactic acidemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, (eds). The metabolic and molecular bases of inherited disease. 8th edn. New York: McGraw-Hill 2001: 2275-2295
• 17 Seyda A, MacEachern G, Haas R, Robinson BH. Sequential deletion of C-terminal amino acids of the E(1)alpha component of the PDH complex leads to reduced steady-state levels of functional E(1)alpha(2)beta(2) tetramers:implications for patients with PDH deficiency.  Hum Mol Genet. 2000;  9 1041-1048
• 18 Sheu KF, Hu CW, Utter MF. Pyruvate dehydrogenase complex activity in normal and deficient fibroblasts.  J Clin Invest. 1981;  67 1463-1471
• 19 Strassburg HM, Koch J, Mayr J, Sperl W, Bolthauser E. Acute flaccid paralysis as initial symptom in 4 patients with novel E1a mutations of the pyruvate dehydrogenase complex.  Neuropediatrics. 2006;  37 137-141

Correspondence